• NUTRYELT is used as part of an intravenous nutrition regimen to meet basal or moderately increased trace element requirements in parenteral nutrition.
• NUTRYELT is indicated for adults only.
• It is used in:
• Gastrointestinal disorders (e.g., short bowel syndrome, Crohn’s disease)
• Post-operative recovery when oral intake is not possible
• Cancer patients receiving chemotherapy or radiotherapy with impaired digestive function
• Neurological conditions where oral or enteral feeding is not feasible
• Burns, trauma, or sepsis requiring nutritional support

Each 10 ml vial contains:

• Ferrous gluconate: Iron (Fe): 1 mg
• Zinc gluconate: Zinc (Zn): 10 mg
• Copper gluconate: Copper (Cu): 0.30 mg
• Manganese gluconate: Manganese (Mn): 0.055 mg
• Sodium fluoride: Fluorine (F): 0.95 mg
• Cobalt (Co): 0.30 mg
• Potassium iodide: Iodine (I): 130 µg
• Sodium selenite: Selenium (Se): 70 µg
• Sodium molybdate: Molybdenum (Mo): 20 µg
• Chromic chloride: Chromium (Cr): 10 µg

NUTRYELT is a balanced parenteral nutrition multi-trace element solution containing nine essential trace elements that helps prevent micronutrient deficiencies and follows international guidelines.

It is a parenteral nutrition solution that delivers essential nutrients directly into the bloodstream, bypassing the gastrointestinal system. The nutrients are metabolized to provide:

• Energy through glucose
• Protein synthesis and tissue repair via amino acids
• Cellular structure and function via lipids and fatty acids
• Metabolic regulation and maintenance of physiological functions through vitamins, minerals, and electrolytes

NUTRYELT supports essential physiological processes such as immune function, cellular repair, and energy production from stored nutrients.

Patients with baseline or moderately increased requirements: 1 ampoule (10 ml) of NUTRYELT/day

Patients with significantly increased TE requirements: 2 ampoules (20 ml) of NUTRYELT/day

Diluted in an infusion solution of 250 ml 0.9% NaCl or 250 ml 5% glucose or added to PN mixtures.

After dilution, the physico-chemical stability of the diluted solution has been demonstrated for 48 hours at 25°C protected from light.

Drug interactions: Parenteral nutrition may interact with certain medications, particularly those that affect nutrient metabolism (e.g., insulin for glucose control, diuretics for electrolyte balance).

Electrolyte imbalances: Drugs affecting kidney or liver function may also alter electrolyte balance, which should be managed with careful monitoring.

• Children or patients <40 kg
• Severe cholestasis (bilirubin levels >140 µmol/L)
• Hypersensitivity to any of the active substances or excipients
• Wilson’s disease
• Hemochromatosis
• Elevated serum concentrations of any of the NUTRYELT constituents

Hyperglycemia due to glucose content.
Electrolyte imbalances such as changes in sodium, potassium, or calcium levels.
Infections due to intravenous administration.
Liver dysfunction or fatty liver, especially with prolonged use.
Thrombophlebitis at the injection site.
Gastrointestinal symptoms such as nausea or diarrhea during transition to enteral feeding.

Parenteral nutrition should be used cautiously during pregnancy. The benefits and risks must be carefully evaluated, as maternal malnutrition or electrolyte disturbances may affect fetal development. If necessary, it should be administered under strict medical supervision.

Monitoring required: Regular monitoring of blood glucose, electrolytes, and liver function is essential.

Infection risk: Strict aseptic technique must be followed during intravenous administration to prevent infections.

Fluid overload: Caution is required in patients with renal impairment or heart failure.

Parenteral nutritional preparations

Protected from light, store below 25°C.